Phase 1 Study of B-cell Depletion With Rituximab on Oral, Ocular and General Disease Manifestations in Patients With Primary Sjogren's Syndrome.
Phase of Trial: Phase II
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Rituximab (Primary)
- Indications Sjogren's syndrome
- Focus Therapeutic Use
- 22 Jan 2011 New trial record